We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Noninvasive Ventilator Adapts to Patients' Needs

By HospiMedica staff writers
Posted on 03 Oct 2007
A new home ventilator designed for treating respiratory insufficiency caused by progressive neuromuscular disorders automatically adjusts bilevel positive airway pressure (BiPAP) to meet the patients' changing needs. More...


The Respironics' BiPAP AVAPS noninvasive home ventilator features average volume assured pressure support (AVAPS) technology, an algorithm that provides an average target tidal volume by automatically adapting pressure support to meet the patient's needs. The technology allows clinician to offer the comfort of pressure ventilation and the consistent clinical efficacy of delivering a target tidal volume in a compact, lightweight (1.7 kg) machine. The AVAPS ventilator offers a simple user interface and an integrated heated humidifier that allows for easier set-up and management. It also comes with built-in alarms and proprietary Encore smartcard technology. The AVAPS ventilator is a product of Respironics (Murrysville, PA, USA).

The AVAPS respirator utilizes proprietary digital Auto-Trak sensitivity, which estimates the patient's target tidal volume with each breath and compares it to the desired target tidal volume. If the patient is not achieving the target tidal volume, AVAPS recognizes the problem and gradually changes the inspiratory pressure so that the patient can achieve synchrony, guaranteeing a minimum level of ventilation and simplifying the titration process. Because the pressure increase is smooth, patient comfort and safety are not compromised. The AVAPS ventilator has been approved by the U.S. Food and Drug Administration (FDA).

"Patients deserve efficient and comfortable noninvasive ventilation, and we designed the BiPAP AVAPS ventilator specifically with that in mind,” said Elaine Lesnak, Respironics home respiratory care marketing manager in the United States. "AVAPS combines the comfort and leak compensation of a pressure mode with the safety of a guaranteed volume.”

BiPAP is a pressure generating method for increasing oxygenation and ventilation, usually used to treat people with sleep apnea. Patients wear a mask over their face when they sleep, and every time they exhale, pressurized air from this mask gently pushes its way into the mouth and re-inflates the lungs, effectively starting a new breath.


Related Links:
Respironics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.